Neutrophil-lymphocyte ratio reflects hepatocellular carcinoma recurrence after liver transplantation via inflammatory microenvironment

Journal of Hepatology

Volumn 58, Issue 1, 2013, Pages 58-64

  Motomura, Takashi ^a   Shirabe, Ken ^a   Mano, Yohei ^a   Muto, Jun ^a   Toshima, Takeo ^a   Umemoto, Yuichiro ^a   Fukuhara, Takasuke ^a   Uchiyama, Hideaki ^a   Ikegami, Toru ^a   Yoshizumi, Tomoharu ^a   Soejima, Yuji ^a   Maehara, Yoshihiko ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

HCC; IL 17; Liver transplantation; NLR; TAM

Indexed keywords

ANTINEOPLASTIC AGENT; CD163 ANTIGEN; CD68 ANTIGEN; CYCLOSPORIN A; INTERLEUKIN 17; INTERLEUKIN 8; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID; TACROLIMUS; VASCULOTROPIN;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER PROGNOSIS; CELL DENSITY; CHEMOEMBOLIZATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; LIVER CELL CARCINOMA; LIVER GRAFT REJECTION; LIVER RESECTION; LIVER TRANSPLANTATION; LIVING DONOR; LIVING DONOR LIVER TRANSPLANTATION; LONG TERM CARE; LOW DRUG DOSE; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL COUNT; NEUTROPHIL LYMPHOCYTE RATIO; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIOFREQUENCY ABLATION; RECURRENCE FREE SURVIVAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; TUMOR LOCALIZATION; TUMOR MICROENVIRONMENT; TUMOR RECURRENCE;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; INTERLEUKIN-17; INTERLEUKIN-8; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; LIVER TRANSPLANTATION; LYMPHOCYTE COUNT; LYMPHOCYTES; MACROPHAGES; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEUTROPHILS; PREDICTIVE VALUE OF TESTS; PREOPERATIVE CARE; PROGNOSIS; RISK FACTORS; TUMOR MICROENVIRONMENT; VASCULAR ENDOTHELIAL GROWTH FACTOR A; YOUNG ADULT;

EID: 84871212252     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2012.08.017     Document Type: Article

References (30)

1. V. Mazzaferro, E. Regalia, R. Doci, S. Andreola, A. Pulvirenti, and F. Bozzetti Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis N Engl J Med 334 1996 693 699
2. F.Y. Yao, L. Ferrell, N.M. Bass, J.J. Watson, P. Bacchetti, and A. Venook Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival Hepatology 33 2001 1394 1403
3. V. Mazzaferro, J.M. Llovet, R. Miceli, S. Bhoori, M. Schiavo, and L. Mariani Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis Lancet Oncol 10 2009 35 43
4. A. Taketomi, K. Sanefuji, Y. Soejima, T. Yoshizumi, H. Uhciyama, and T. Ikegami Impact of des-gamma-carboxy prothrombin and tumor size on the recurrence of hepatocellular carcinoma after living donor liver transplantation Transplantation 87 2009 531 537
5. L.M. Coussens, and Z. Werb Inflammation and cancer Nature 420 2002 860 867
6. F. Balkwill, and A. Mantovani Inflammation and cancer: back to Virchow? Lancet 357 2001 539 545
7. M. Jaiswal, N.F. LaRusso, L.J. Burgart, and G.J. Gores Inflammatory cytokines induce DNA damage and inhibit DNA repair in cholangiocarcinoma cells by a nitric oxide-dependent mechanism Cancer Res 60 2000 184 190
8. S.R. Walsh, E.J. Cook, F. Goulder, T.A. Justin, and N.J. Keeling Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer J Surg Oncol 91 2005 181 184
9. D. Gomez, S. Farid, H.Z. Malik, A.L. Young, G.J. Toogood, and J.P. Lodge Preoperative neutrophil-to-lymphocyte ratio as a prognostic predictor after curative resection for hepatocellular carcinoma World J Surg 32 2008 1757 1762
10. D. Gomez, G. Morris-Stiff, G.J. Toogood, J.P. Lodge, and K.R. Prasad Impact of systemic inflammation on outcome following resection for intrahepatic cholangiocarcinoma J Surg Oncol 97 2008 513 518
11. I. Bhatti, O. Peacock, G. Lloyd, M. Larvin, and R.I. Hall Preoperative hematologic markers as independent predictors of prognosis in resected pancreatic ductal adenocarcinoma: neutrophil-lymphocyte versus platelet-lymphocyte ratio Am J Surg 200 2010 197 203
12. K.J. Halazun, M.A. Hardy, A.A. Rana, D.C. Woodland 4th, E.J. Luyten, and S. Mahadev Negative impact of neutrophil-lymphocyte ratio on outcome after liver transplantation for hepatocellular carcinoma Ann Surg 250 2009 141 151
13. C.M. Lo, S.T. Fan, C.L. Liu, S.C. Chan, and J. Wong The role and limitation of living donor liver transplantation for hepatocellular carcinoma Liver Transpl 10 2004 440 447
14. Y. Soejima, A. Taketomi, T. Yoshizumi, H. Uchiyama, S. Aishima, and T. Terashi Extended indication for living donor liver transplantation in patients with hepatocellular carcinoma Transplantation 83 2007 893 899
15. E.V. Acosta-Rodriguez, L. Rivino, J. Geginat, D. Jarrossay, M. Gattorno, and A. Lanzavecchia Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells Nat Immunol 8 2007 639 646
16. J.W. Pollard Tumour-educated macrophages promote tumour progression and metastasis Nat Rev Cancer 4 2004 71 78
17. V. Cortez-Retamozo, M. Etzrodt, A. Newton, P.J. Rauch, A. Chudnovskiy, and C. Berger Origins of tumor-associated macrophages and neutrophils Proc Natl Acad Sci U S A 109 2012 2491 2496
18. V.R. Bertuzzo, M. Cescon, M. Ravaioli, G.L. Grazi, G. Ercolani, and M. Del Gaudio Analysis of factors affecting recurrence of hepatocellular carcinoma after liver transplantation with a special focus on inflammation markers Transplantation 91 2011 1279 1285
19. D.J. Waugh, and C. Wilson The interleukin-8 pathway in cancer Clin Cancer Res 14 2008 6735 6741
20. D.M. Kuang, C. Peng, Q. Zhao, Y. Wu, L.Y. Zhu, and J. Wang Tumor-activated monocytes promote expansion of IL-17-producing CD8+ T cells in hepatocellular carcinoma patients J Immunol 185 2010 1544 1549
21. D.M. Kuang, Q. Zhao, Y. Wu, C. Peng, J. Wang, and Z. Xu Peritumoral neutrophils link inflammatory response to disease progression by fostering angiogenesis in hepatocellular carcinoma J Hepatol 54 2011 948 955
22. H. Kono, H. Fujii, M. Ogiku, N. Hosomura, H. Amemiya, and M. Tsuchiya Role of IL-17A in neutrophil recruitment and hepatic injury after warm ischemia-reperfusion mice J Immunol 187 2011 4818 4825
23. D.M. Kuang, C. Peng, Q. Zhao, Y. Wu, M.S. Chen, and L. Zheng Activated monocytes in peritumoral stroma of hepatocellular carcinoma promote expansion of memory T helper 17 cells Hepatology 51 2010 154 164
24. I. Daurkin, E. Eruslanov, T. Stoffs, G.Q. Perrin, C. Algood, and S.M. Gilbert Tumor-associated macrophages mediate immunosuppression in the renal cancer microenvironment by activating the 15-lipoxygenase-2 pathway Cancer Res 71 2011 6400 6409
25. M. Tosolini, A. Kirilovsky, B. Mlecnik, T. Fredriksen, S. Mauger, and G. Bindea Clinical impact of different classes of infiltrating T cytotoxic and helper cells (Th1, Th2, Treg, Th17) in patients with colorectal cancer Cancer Res 71 2011 1263 1271
26. H. Hasita, Y. Komohara, H. Okabe, T. Masuda, K. Ohnishi, and X.F. Lei Significance of alternatively activated macrophages in patients with intrahepatic cholangiocarcinoma Cancer Sci 101 2010 1913 1919
27. J. Li, G.K. Lau, L. Chen, S.S. Dong, H.Y. Lan, and X.R. Huang Interleukin 17A promotes hepatocellular carcinoma metastasis via NF-kB induced matrix metalloproteinases 2 and 9 expression PLoS ONE 6 2011 e21816
28. Q. Zhao, X. Xiao, Y. Wu, Y. Wei, L.Y. Zhu, and J. Zhou Interleukin-17-educated monocytes suppress cytotoxic T-cell function through B7-H1 in hepatocellular carcinoma patients Eur J Immunol 41 2011 2314 2322
29. D.M. Kuang, Q. Zhao, C. Peng, J. Xu, J.P. Zhang, and C. Wu Activated monocytes in peritumoral stroma of hepatocellular carcinoma foster immune privilege and disease progression through PD-L1 J Exp Med 206 2009 1327 1337
30. G. Radosavljevic, B. Ljujic, I. Jovanovic, Z. Srzentic, S. Pavlovic, and N. Zdravkovic Interleukin-17 may be a valuable serum tumor marker in patients with colorectal carcinoma Neoplasma 57 2010 135 144